NSPR logo

NSPRInspireMD Inc

$0.9957
$0.0356
(3.71%)
Pre-Market
Updated: 08:21 AM EDT·Prev Close $0.9601
EarningsAug 11
Mkt Cap$44.97M
Vol15.00
News
all
press releases
InspireMD NSPR Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance
The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures.
Stocktwits
News Placeholder
InspireMD (NYSE:NSPR) Stock Price Up 3.5% - What's Next?
InspireMD (NYSE:NSPR) Stock Price Up 3.5% - Here's What Happened...
MarketBeat
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire
News Placeholder
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)
InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks
News Placeholder
InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?
InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...
MarketBeat
News Placeholder
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC
Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat
News Placeholder
Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR
Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat
<
1
2
...
>